181 related articles for article (PubMed ID: 28758988)
1. Beneficial Effects of Galectin-3 Blockade in Vascular and Aortic Valve Alterations in an Experimental Pressure Overload Model.
Ibarrola J; Martínez-Martínez E; Sádaba JR; Arrieta V; García-Peña A; Álvarez V; Fernández-Celis A; Gainza A; Rossignol P; Cachofeiro Ramos V; López-Andrés N
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758988
[TBL] [Abstract][Full Text] [Related]
2. Role for Galectin-3 in Calcific Aortic Valve Stenosis.
Sádaba JR; Martínez-Martínez E; Arrieta V; Álvarez V; Fernández-Celis A; Ibarrola J; Melero A; Rossignol P; Cachofeiro V; López-Andrés N
J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27815266
[TBL] [Abstract][Full Text] [Related]
3. Sex-specific role of galectin-3 in aortic stenosis.
Matilla L; Martín-Núñez E; Garaikoetxea M; Navarro A; Tamayo I; Fernández-Celis A; Gainza A; Fernández-Irigoyen J; Santamaría E; Muntendam P; Álvarez V; Sádaba R; Jover E; López-Andrés N
Biol Sex Differ; 2023 Oct; 14(1):72. PubMed ID: 37875993
[TBL] [Abstract][Full Text] [Related]
4. Galectin-3 Blockade Reduces Renal Fibrosis in Two Normotensive Experimental Models of Renal Damage.
Martinez-Martinez E; Ibarrola J; Calvier L; Fernandez-Celis A; Leroy C; Cachofeiro V; Rossignol P; Lopez-Andres N
PLoS One; 2016; 11(11):e0166272. PubMed ID: 27829066
[TBL] [Abstract][Full Text] [Related]
5. A role for galectin-3 in the development of early molecular alterations in short-term aortic stenosis.
Arrieta V; Martinez-Martinez E; Ibarrola J; Alvarez V; Sádaba R; Garcia-Peña A; Fernández-Celis A; Cachofeiro V; Rossignol P; López-Andrés N
Clin Sci (Lond); 2017 May; 131(10):935-949. PubMed ID: 28360193
[TBL] [Abstract][Full Text] [Related]
6. Galectin-3 Participates in Cardiovascular Remodeling Associated With Obesity.
Martínez-Martínez E; López-Ándres N; Jurado-López R; Rousseau E; Bartolomé MV; Fernández-Celis A; Rossignol P; Islas F; Antequera A; Prieto S; Luaces M; Cachofeiro V
Hypertension; 2015 Nov; 66(5):961-9. PubMed ID: 26351031
[TBL] [Abstract][Full Text] [Related]
7. Galectin-3 pharmacological inhibition attenuates early renal damage in spontaneously hypertensive rats.
Martínez-Martínez E; Ibarrola J; Fernández-Celis A; Calvier L; Leroy C; Cachofeiro V; Rossignol P; López-Andrés N
J Hypertens; 2018 Feb; 36(2):368-376. PubMed ID: 28858976
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension.
Martínez-Martínez E; Calvier L; Fernández-Celis A; Rousseau E; Jurado-López R; Rossoni LV; Jaisser F; Zannad F; Rossignol P; Cachofeiro V; López-Andrés N
Hypertension; 2015 Oct; 66(4):767-75. PubMed ID: 26238446
[TBL] [Abstract][Full Text] [Related]
9. A novel mouse model of aortic valve stenosis induced by direct wire injury.
Honda S; Miyamoto T; Watanabe T; Narumi T; Kadowaki S; Honda Y; Otaki Y; Hasegawa H; Netsu S; Funayama A; Ishino M; Nishiyama S; Takahashi H; Arimoto T; Shishido T; Miyashita T; Kubota I
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):270-8. PubMed ID: 24311378
[TBL] [Abstract][Full Text] [Related]
10. Galectin-3 inhibition prevents adipose tissue remodelling in obesity.
Martínez-Martínez E; Calvier L; Rossignol P; Rousseau E; Fernández-Celis A; Jurado-López R; Laville M; Cachofeiro V; López-Andrés N
Int J Obes (Lond); 2016 Jun; 40(6):1034-8. PubMed ID: 26853916
[TBL] [Abstract][Full Text] [Related]
11. Endoplasmic reticulum stress participates in aortic valve calcification in hypercholesterolemic animals.
Cai Z; Li F; Gong W; Liu W; Duan Q; Chen C; Ni L; Xia Y; Cianflone K; Dong N; Wang DW
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2345-54. PubMed ID: 23928865
[TBL] [Abstract][Full Text] [Related]
12. A Role for MMP-10 (Matrix Metalloproteinase-10) in Calcific Aortic Valve Stenosis.
Matilla L; Roncal C; Ibarrola J; Arrieta V; García-Peña A; Fernández-Celis A; Navarro A; Álvarez V; Gainza A; Orbe J; Cachofeiro V; Zalba G; Sádaba R; Rodríguez JA; López-Andrés N
Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1370-1382. PubMed ID: 32188274
[TBL] [Abstract][Full Text] [Related]
13. Fibrotic Aortic Valve Stenosis in Hypercholesterolemic/Hypertensive Mice.
Chu Y; Lund DD; Doshi H; Keen HL; Knudtson KL; Funk ND; Shao JQ; Cheng J; Hajj GP; Zimmerman KA; Davis MK; Brooks RM; Chapleau MW; Sigmund CD; Weiss RM; Heistad DD
Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):466-74. PubMed ID: 26769049
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice.
Vergaro G; Prud'homme M; Fazal L; Merval R; Passino C; Emdin M; Samuel JL; Cohen Solal A; Delcayre C
Hypertension; 2016 Mar; 67(3):606-12. PubMed ID: 26781273
[TBL] [Abstract][Full Text] [Related]
15. Calcific Aortic Valve Disease: Part 1--Molecular Pathogenetic Aspects, Hemodynamics, and Adaptive Feedbacks.
Pasipoularides A
J Cardiovasc Transl Res; 2016 Apr; 9(2):102-18. PubMed ID: 26891845
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory and metabolic mechanisms underlying the calcific aortic valve disease.
Cho KI; Sakuma I; Sohn IS; Jo SH; Koh KK
Atherosclerosis; 2018 Oct; 277():60-65. PubMed ID: 30173080
[TBL] [Abstract][Full Text] [Related]
17. Warfarin, but not rivaroxaban, promotes the calcification of the aortic valve in ApoE-/- mice.
Rattazzi M; Faggin E; Bertacco E; Nardin C; Pagliani L; Plebani M; Cinetto F; Guidolin D; Puato M; Pauletto P
Cardiovasc Ther; 2018 Aug; 36(4):e12438. PubMed ID: 29847020
[TBL] [Abstract][Full Text] [Related]
18. Galectin-3 mediates aldosterone-induced vascular fibrosis.
Calvier L; Miana M; Reboul P; Cachofeiro V; Martinez-Martinez E; de Boer RA; Poirier F; Lacolley P; Zannad F; Rossignol P; López-Andrés N
Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):67-75. PubMed ID: 23117656
[TBL] [Abstract][Full Text] [Related]
19. miR-214 is Stretch-Sensitive in Aortic Valve and Inhibits Aortic Valve Calcification.
Salim MT; Esmerats JF; Arjunon S; Villa-Roel N; Nerem RM; Jo H; Yoganathan AP
Ann Biomed Eng; 2019 Apr; 47(4):1106-1115. PubMed ID: 30671754
[TBL] [Abstract][Full Text] [Related]
20. Myocardial Injury After Ischemia/Reperfusion Is Attenuated By Pharmacological Galectin-3 Inhibition.
Ibarrola J; Matilla L; Martínez-Martínez E; Gueret A; Fernández-Celis A; Henry JP; Nicol L; Jaisser F; Mulder P; Ouvrard-Pascaud A; López-Andrés N
Sci Rep; 2019 Jul; 9(1):9607. PubMed ID: 31270370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
